Clinical trial

Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With…

NCT00363805 · Sherry Chow, Other · Completed

Key facts

NCT number NCT00363805
Title Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
Official title Chemoprevention of Lung Carcinogenesis Using Green Tea: Phase IIb Randomized, Double-Blinded, Placebo Controlled Trial of Green Tea and Polyphenon E in Former Smokers With Chronic Obstructive Lung Disease (COPD)
Lead sponsor Sherry Chow, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Lung Cancer Prevention
Intervention type Dietary Supplement, Drug, Other
Interventions green tea, Polyphenon E, placebo
Enrollment 178
Start date May 1, 2004
Primary completion Mar 1, 2009
First posted Aug 15, 2006
Last update posted Nov 28, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies